Development Level

Tbio 5 | 10,625
Tchem 2 | 1,890

Disease

Cancer 5 | 2,346
osteosarcoma 4 | 7,933
Ataxia telangiectasia 3 | 31
Breast cancer 3 | 3,094
Fanconi's anemia 3 | 50
lung cancer 3 | 4,466
ovarian cancer 3 | 8,484
Anemia 2 | 252
Breast Cancer, Familial 2 | 12
Carcinoma 2 | 2,147
Cowden disease 2 | 16
Hereditary Breast and Ovarian Cancer Syndrome 2 | 14
Hereditary breast ovarian cancer 2 | 6
Li-Fraumeni Syndrome 2 | 13
Lobular neoplasia 2 | 15
Lynch syndrome 2 | 33
Malignant neoplasm of breast 2 | 63
Malignant neoplasm of ovary 2 | 13
Mammary Neoplasms 2 | 410
Neoplastic Syndromes, Hereditary 2 | 48
Pancreatic Neoplasm 2 | 79
Pancreatic carcinoma, familial 2 | 8
Peripheral Neuropathy 2 | 303
Premature menopause 2 | 7
Prostate cancer 2 | 172
Prostate cancer, familial 2 | 13
Prostatic Neoplasms 2 | 471
colon cancer 2 | 1,475
ductal carcinoma in situ 2 | 1,745
glioblastoma 2 | 5,572
group 3 medulloblastoma 2 | 2,254
intraductal papillary-mucinous carcinoma (IPMC) 2 | 2,988
intraductal papillary-mucinous neoplasm (IPMN) 2 | 3,289
malignant mesothelioma 2 | 3,162
medulloblastoma, large-cell 2 | 6,234
ovarian neoplasm 2 | 97
primitive neuroectodermal tumor 2 | 3,031
psoriasis 2 | 6,685
Adenoid Cystic Carcinoma 1 | 99
Animal Mammary Neoplasms 1 | 136
Autistic Disorder 1 | 320
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1 1 | 7
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2 1 | 1
Breast disease 1 | 8
Chromosome 3q29 microdeletion syndrome 1 | 8
Chromosome Breakage 1 | 5
Dysplastic nevus syndrome 1 | 7
Embryo Loss 1 | 9
FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder) 1 | 2
FANCONI ANEMIA, COMPLEMENTATION GROUP D1 1 | 1
Fanconi Anemia 1 | 19
GLIOMA SUSCEPTIBILITY 3 1 | 1
Glioma 1 | 65
Lung Neoplasms 1 | 171
MOYAMOYA DISEASE 4 WITH SHORT STATURE, HYPERGONADOTROPIC HYPOGONADISM, AND FACIAL DYSMORPHISM 1 | 1
Malignant neoplasm of lung 1 | 16
Malignant neoplasm of prostate 1 | 67
Mammary Neoplasms, Experimental 1 | 150
Menopause present (finding) 1 | 20
Morgagni cataract 1 | 1
Mouth Diseases 1 | 12
Neoplastic Cell Transformation 1 | 81
Nephroblastoma 1 | 45
Nijmegen breakage syndrome 1 | 23
PANCREATIC CANCER, SUSCEPTIBILITY TO, 2 1 | 1
PANCREATIC CANCER, SUSCEPTIBILITY TO, 4 1 | 1
PITUITARY DWARFISM I 1 | 6
Peutz-Jeghers syndrome 1 | 23
Pick disease 1 | 1,893
Rheumatoid Arthritis 1 | 1,160
Riddle Syndrome 1 | 1
Squamous Cell Neoplasms 1 | 3
Waldenstrons macroglobulinemia 1 | 765
active Crohn's disease 1 | 918
astrocytic glioma 1 | 2,241
atypical teratoid/rhabdoid tumor 1 | 1,095
ependymoma 1 | 2,514
hereditary spastic paraplegia 1 | 313
invasive ductal carcinoma 1 | 2,950
lung adenocarcinoma 1 | 2,713
lung carcinoma 1 | 2,844
medulloblastoma 1 | 1,524
nasopharyngeal carcinoma 1 | 1,056
non primary Sjogren syndrome sicca 1 | 840
non-small cell lung cancer 1 | 2,798
oligodendroglioma 1 | 2,849
pediatric high grade glioma 1 | 2,712
pituitary cancer 1 | 1,972
posterior fossa group A ependymoma 1 | 1,511
sonic hedgehog group medulloblastoma 1 | 1,482
subependymal giant cell astrocytoma 1 | 2,287

Tissue

Blood and immune system 7 | 17,995
Cardiovascular System 7 | 17,958
Digestive Tract 7 | 18,473
Endocrine System 7 | 18,512
Female tissues 7 | 18,647
Liver and Pancreas 7 | 18,136
Male tissues 7 | 17,969
Nervous System 7 | 18,561
Respiratory system 7 | 17,484
Skin and soft tissues 7 | 18,115
Urinary Tract 7 | 18,444

Target Family

Non-IDG 4 | 11,971
Enzyme 3 | 4,146

Grant Application

5R01CA138835-04 7 | 7
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
E3 ubiquitin-protein ligase RNF168 RNF168 Tbio Enzyme -1.46566 28.7 150
Ubiquitin-conjugating enzyme E2 N UBE2N Tchem Non-IDG -2.02460 99.0 237
E3 ubiquitin-protein ligase RNF8 RNF8 Tbio Enzyme -1.74520 64.0 226
Breast cancer type 2 susceptibility protein BRCA2 Tbio Non-IDG -3.42019 2495.6 219
Breast cancer type 1 susceptibility protein BRCA1 Tchem Non-IDG -3.72596 5756.8 1322
BRCA1-A complex subunit RAP80 UIMC1 Tbio Non-IDG -1.66067 49.7 167
Lys-63-specific deubiquitinase BRCC36 BRCC3 Tbio Enzyme -1.06699 11.8 187